NCT07052071View on ClinicalTrials.gov

Impact of Transcatheter Aortic Valve Implantation (TAVI) on the Gut Microbiota in Patients With Aortic Valve Stenosis

Not yet recruitingOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

September 1, 2027

Study Completion Date

November 1, 2027

Conditions
Aortic StenosisGut MicrobiomeGut MicrobiotaTAVITAVI(Transcatheter Aortic Valve Implantation)
Interventions
PROCEDURE

TAVI

Transcatheter Aortic Valve Implantation (TAVI) is a minimally invasive method for replacing the aortic valve in patients with severe aortic stenosis. The procedure involves the placement of a bioprosthetic valve within the patient's degenerated aortic valve via a catheter.

Trial Locations (1)

Unknown

Hippokration General Hospital of Athens, Athens

All Listed Sponsors
lead

Hippocration General Hospital

OTHER

NCT07052071 - Impact of Transcatheter Aortic Valve Implantation (TAVI) on the Gut Microbiota in Patients With Aortic Valve Stenosis | Biotech Hunter | Biotech Hunter